Kyle Rose
Stock Analyst at Canaccord Genuity
(3.31)
# 1,013
Out of 4,711 analysts
114
Total ratings
52.69%
Success rate
12.78%
Average return
Main Sectors:
Stocks Rated by Kyle Rose
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| FNA Paragon 28 | Maintains: Buy | $17 → $15 | $10.03 | +49.55% | 3 | Nov 13, 2024 | |
| SYK Stryker | Maintains: Buy | $360 → $400 | $364.60 | +9.71% | 19 | Oct 30, 2024 | |
| PODD Insulet | Maintains: Buy | $226 → $234 | $266.57 | -12.22% | 15 | May 10, 2024 | |
| GMED Globus Medical | Maintains: Buy | $67 → $71 | $82.63 | -14.07% | 7 | Dec 20, 2023 | |
| ENOV Enovis | Maintains: Buy | $65 → $71 | $43.12 | +64.66% | 3 | Dec 20, 2023 | |
| INMD InMode | Downgrades: Hold | $55 → $22 | $17.08 | +28.81% | 10 | Oct 13, 2023 | |
| SKIN The Beauty Health Company | Assumes: Buy | $10 | $1.46 | +584.93% | 4 | Aug 25, 2023 | |
| ATEC Alphatec Holdings | Maintains: Buy | $17 → $22 | $9.35 | +135.29% | 4 | Aug 4, 2023 | |
| DXCM DexCom | Maintains: Buy | $135 → $150 | $80.04 | +87.41% | 17 | Jul 28, 2023 | |
| RBOT Vicarious Surgical | Maintains: Buy | $360 → $270 | $12.00 | +2,150.00% | 3 | May 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $24 → $27 | $13.25 | +103.77% | 3 | May 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $2.85 | +426.32% | 1 | Mar 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $15.64 | -4.09% | 6 | Mar 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $125 → $122 | $150.31 | -18.83% | 1 | Mar 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $3 → $4 | $4.02 | -0.50% | 4 | Nov 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $10.67 | - | 2 | Nov 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $165 → $125 | $107.12 | +16.69% | 7 | Feb 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $53 → $55 | $24.66 | +123.03% | 5 | Apr 30, 2021 |
Paragon 28
Nov 13, 2024
Maintains: Buy
Price Target: $17 → $15
Current: $10.03
Upside: +49.55%
Stryker
Oct 30, 2024
Maintains: Buy
Price Target: $360 → $400
Current: $364.60
Upside: +9.71%
Insulet
May 10, 2024
Maintains: Buy
Price Target: $226 → $234
Current: $266.57
Upside: -12.22%
Globus Medical
Dec 20, 2023
Maintains: Buy
Price Target: $67 → $71
Current: $82.63
Upside: -14.07%
Enovis
Dec 20, 2023
Maintains: Buy
Price Target: $65 → $71
Current: $43.12
Upside: +64.66%
InMode
Oct 13, 2023
Downgrades: Hold
Price Target: $55 → $22
Current: $17.08
Upside: +28.81%
The Beauty Health Company
Aug 25, 2023
Assumes: Buy
Price Target: $10
Current: $1.46
Upside: +584.93%
Alphatec Holdings
Aug 4, 2023
Maintains: Buy
Price Target: $17 → $22
Current: $9.35
Upside: +135.29%
DexCom
Jul 28, 2023
Maintains: Buy
Price Target: $135 → $150
Current: $80.04
Upside: +87.41%
Vicarious Surgical
May 31, 2023
Maintains: Buy
Price Target: $360 → $270
Current: $12.00
Upside: +2,150.00%
May 2, 2023
Maintains: Buy
Price Target: $24 → $27
Current: $13.25
Upside: +103.77%
Mar 28, 2023
Reiterates: Buy
Price Target: $15
Current: $2.85
Upside: +426.32%
Mar 28, 2023
Reiterates: Buy
Price Target: $15
Current: $15.64
Upside: -4.09%
Mar 1, 2023
Maintains: Market Perform
Price Target: $125 → $122
Current: $150.31
Upside: -18.83%
Nov 10, 2022
Upgrades: Buy
Price Target: $3 → $4
Current: $4.02
Upside: -0.50%
Nov 9, 2022
Downgrades: Hold
Price Target: n/a
Current: $10.67
Upside: -
Feb 8, 2022
Downgrades: Hold
Price Target: $165 → $125
Current: $107.12
Upside: +16.69%
Apr 30, 2021
Maintains: Buy
Price Target: $53 → $55
Current: $24.66
Upside: +123.03%